You are here » Home » Companies » Company Overview » Sanofi India Ltd

Sanofi India Ltd.

BSE: 500674 Sector: Health care
NSE: SANOFI ISIN Code: INE058A01010
BSE 00:00 | 01 Jul 6367.75 -68.65
(-1.07%)
OPEN

6376.05

HIGH

6419.05

LOW

6340.00

NSE 00:00 | 01 Jul 6378.35 -59.05
(-0.92%)
OPEN

6415.00

HIGH

6435.05

LOW

6333.00

OPEN 6376.05
PREVIOUS CLOSE 6436.40
VOLUME 417
52-Week high 9300.00
52-Week low 6320.70
P/E 25.15
Mkt Cap.(Rs cr) 14,665
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 6376.05
CLOSE 6436.40
VOLUME 417
52-Week high 9300.00
52-Week low 6320.70
P/E 25.15
Mkt Cap.(Rs cr) 14,665
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Sanofi India Ltd. (SANOFI) - Chairman Speech

Company chairman speech

Dear Shareholders

The last year saw India and the rest of the world begin to recover fromthe substantial disruptions caused by COVID-19 but with the repeating waves of thepandemic and the recent geo-political tensions it is likely that the business environmentwill remain volatile for some more time. Despite this it is indeed encouraging to notethat in the long-term India continues to raise expectations of being amongst the fastestgrowing economies in the world. The pandemic highlighted the shortcomings in India'shealthcare infrastructure and the government has already increased the outlay to buildcapabilities for the future. All this augers well for the Indian pharmaceutical industry.

Through all the uncertainties it was heartening to see organisationswith a clear purpose and responsible leadership continue to rapidly reinvent themselvesand stay future relevant.

During the year your Company has successfully implemented a variety oftransformational initiatives to deliver market-beating growth in key therapies therebysignificantly improving its overall financials. During these challenging times all itsemployees have worked tirelessly to help patients manage their disease effectivelyensuring that there were no major disruptions to the supplies or service to itsstakeholders.

Your Company has also pioneered several corporate social responsibilityinitiatives to improve the management of non-communicable diseases through capacitybuilding and education of stakeholders and communities. As is well-known your Companytransparently follows global ethical practices and strictly adheres to the higheststandards of corporate governance. You will find more details of your company's activitiesin this report.

On behalf of all the Board members I would like to thank all theemployees for their extraordinary perseverance and commitment and all the otherstakeholders and shareholders for their trust in all our endeavours.

Look forward to your continued support and best wishes for yourwell-being.

Yours sincerely

Aditya Narayan

.